Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines (Q40577551)
Jump to navigation
Jump to search
scientific article published on March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines |
scientific article published on March 2004 |
Statements
1 reference
Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines (English)
1 reference
Sandra Huguenin
1 reference
Francis Vacherot
1 reference
Laurence Kheuang
1 reference
Jocelyne Fleury-Feith
1 reference
Marie-Claude Jaurand
1 reference
Manlio Bolla
1 reference
Jean-Pierre Riffaud
1 reference
Dominique K Chopin
1 reference
1 March 2004
1 reference
1 reference
3
1 reference
3
1 reference
291-298
1 reference
Identifiers
1 reference